National Academies Press: OpenBook

Advancing Nuclear Medicine Through Innovation (2007)

Chapter: Appendix B Glossary and Acronyms

« Previous: Appendix A Information-Gathering Sessions
Suggested Citation:"Appendix B Glossary and Acronyms." Institute of Medicine and National Research Council. 2007. Advancing Nuclear Medicine Through Innovation. Washington, DC: The National Academies Press. doi: 10.17226/11985.
×

Appendix B
Glossary and Acronyms

Accelerator: A machine used to accelerate charged particles to high energies to create radionuclides.

Agreement States: States to which the U.S. Nuclear Regulatory Commission (U.S. NRC) has transferred its regulatory authority. Transfer of U.S. NRC’s authority to a state is an agreement that is signed by the governor of the state and the chairman of the commission.

Alpha particle: Subatomic matter consisting of two protons and two neutrons.

Antibody: A protein made by the immune system to detect and destroy foreign intruders, such as viruses and bacteria.

Antigen: Substances such as proteins that elicit an immune response.

Atherosclerosis: A cardiovascular disease in which fatty material builds up in the arteries.

Auger electron: The second electron that is ejected when emission of an initial electron from an atom causes an emission of a second electron.

Authorized user: The U.S. NRC regulates the use of radioactive material used in medicine by issuing licenses to medical facilities and users. Research using radioactive materials on human subjects may only be performed if the licensee has fulfilled the requirements outlined in 10 CFR Part 35, which include completing a minimum of 700 hours of training.

B-cells: Lymphocytes that are produced in the bone marrow, which play an important role in immune response.

Suggested Citation:"Appendix B Glossary and Acronyms." Institute of Medicine and National Research Council. 2007. Advancing Nuclear Medicine Through Innovation. Washington, DC: The National Academies Press. doi: 10.17226/11985.
×

Combinatorial library: Sets of compounds prepared using combinatorial chemistry, which allow scientists to access a wide range of substances and to search for compounds that bind to specific biological and non-biological targets.

Cyclotron: Circular accelerator.

Excitation function: The amount of radionuclide produced is dependent upon the energy of the particle with which the target is bombarded. The yield of the radioactive product versus the energy of the particle is called an excitation function.

Genomics: Describes molecular assessment of the entire genome.

Half-life: The length of time it takes for one-half of the radioactive material to decay by emitting radiation.

Hot atom chemistry: The study of the chemical reactions that occur between high-energy atoms or molecules.

Hypoxia: Shortage of oxygen or reduction in the concentration of oxygen in the environment.

Materials science: An interdisciplinary field comprising applied physics, chemistry, and engineering that studies the physical properties of matter and its applications.

Microfluidics: A multidisciplinary field that studies how fluids behave at microliter and nanoliter volumes and the design of systems in which small volumes of fluids will be used to provide automated sample processing, synthesis, separation, and measurements in devices commonly described by the term “lab-on-a-chip.”

Minimal residual disease: Presence of residual malignant cells, even when few cancer cells can be detected by conventional means (i.e., at subclinical level).

Molecular imaging: Scientific discipline that studies new ways of imaging molecular events and biochemical reactions in a living organism using labeled tracers with high molecular specificity.

Monoclonal antibody: Antibodies that are identical and produced by one type of immune cell.

Nanotechnology: Broad scientific field that creates and uses materials and devices on the nanoscale (i.e., 10−9).

Neurotransmitters: Chemicals that relay signals between the brain and other cells, for example, dopamine and serotonin.

Personalized medicine: Tailoring of strategies to detect, treat, and prevent disease based on an individual’s genetic profile.

Pharmacodynamics: A branch of pharmacology that studies what a drug does to the body.

Suggested Citation:"Appendix B Glossary and Acronyms." Institute of Medicine and National Research Council. 2007. Advancing Nuclear Medicine Through Innovation. Washington, DC: The National Academies Press. doi: 10.17226/11985.
×

Pharmacokinetics: A branch of pharmacology that studies what the body does to the drug (i.e., how it is absorbed, distributed, metabolized, and excreted).

Positron: An elementary particle of antimatter that undergoes mutual annihilation with a nearby electron, which produces two gamma rays traveling in opposite directions.

Proteomics: Comprehensive analysis of the proteins found in cells and tissues.

Radionuclide: An atom with an unstable nucleus that emits gamma-rays, x-ray photons, or positrons, and also known as a radioisotope.

Radiopharmaceutical: Radioactive drug composed of a radionuclide and a pharmaceutical that is used for diagnosis or therapy.

Refractory disease: A condition that is unresponsive to treatment.

Scintillator: A substance that absorbs high-energy charged-particle radiation and then releases this energy through fluorescence.

Sensitivity: Percentage of radioactive decays that are detected by an imaging instrument.

Specific activity: Amount of radioactivity of a specific radionuclide or labeled compound divided by the mass of the radionuclide or labeled compound to which it has been incorporated.

Stage: A method of classifying patients by how far a disease has progressed.

Systems biology: A discipline that models the interactions within a biological system and studies how these interactions give rise to the function and behavior of that system.

Target: An element or chemical compound that is irradiated in an accelerator or reactor to produce a radionuclide.

Targeted radionuclide therapy: A form of treatment that delivers therapeutic doses of radiation to malignant tumors, for example, by administration of a radiolabeled molecule designed to seek out certain cells.

Targetry: Study of cyclotron target composition and structure to optimize the production of a desired nuclide from the “target” and minimize impurities made through nuclear reactions.

Time-of-flight: For each annihilation event the precise time that each of the coincident photons is detected is noted and the difference in arrival time is calculated.

Tracer: A measurable substance used to mimic, follow, or trace a chemical compound or element without perturbing the process.

Suggested Citation:"Appendix B Glossary and Acronyms." Institute of Medicine and National Research Council. 2007. Advancing Nuclear Medicine Through Innovation. Washington, DC: The National Academies Press. doi: 10.17226/11985.
×

ACRONYMS

ACRIN American College of Radiology Imaging Network

AEC Atomic Energy Commission

BERAC Biological and Environmental Research Advisory Committee

BNL Brookhaven National Laboratory

CEA carcinoembryonic antigen

cGMP current Good Manufacturing Practices

CMS Centers for Medicare and Medicaid Services

CT computed tomography

DOE U.S. Department of Energy

DOE-NE Department of Energy Office of Nuclear Energy

DOE-OBER Department of Energy Office of Biological and Environmental Research

eIND Exploratory Investigational New Drug

ERDA Energy Research and Development Agency

FDA U. S. Food and Drug Administration

FDG 2-deoxy-2-[18F]fluoro-d-glucose (also called fluorodeoxyglucose)

GBM glioblastoma multiforme

HIPAA Health Insurance Portability and Accountability Act

IAEA International Atomic Energy Agency

IND Investigational New Drug

INL Idaho National Laboratory

IRB Institutional Review Board

LANL Los Alamos National Laboratory

MIBG meta-iodobenylguanidine

MRI magnetic resonance imaging

MURR Missouri University Research Reactor

NCI National Cancer Institute

NEMA National Electrical Manufacturers Association

NERAC Nuclear Energy Research Advisory Committee

NHLBI National Heart, Lung, and Blood Institute

NIBIB National Institute of Biomedical Imaging and Bioengineering

NIDA National Institute of Drug Abuse

NIH National Institutes of Health

NIMH National Institute of Mental Health

NINDS National Institute of Neurological Disorders and Stroke

NRC U.S. Nuclear Regulatory Commission

ORNL Oak Ridge National Laboratory

Suggested Citation:"Appendix B Glossary and Acronyms." Institute of Medicine and National Research Council. 2007. Advancing Nuclear Medicine Through Innovation. Washington, DC: The National Academies Press. doi: 10.17226/11985.
×

PET positron emission tomography

R&D research and development

RIBBE radiation-induced biological bystander effect

SPECT single photon emission computed tomography

TRIUMF Tri-University Meson Facility

Suggested Citation:"Appendix B Glossary and Acronyms." Institute of Medicine and National Research Council. 2007. Advancing Nuclear Medicine Through Innovation. Washington, DC: The National Academies Press. doi: 10.17226/11985.
×
Page 146
Suggested Citation:"Appendix B Glossary and Acronyms." Institute of Medicine and National Research Council. 2007. Advancing Nuclear Medicine Through Innovation. Washington, DC: The National Academies Press. doi: 10.17226/11985.
×
Page 147
Suggested Citation:"Appendix B Glossary and Acronyms." Institute of Medicine and National Research Council. 2007. Advancing Nuclear Medicine Through Innovation. Washington, DC: The National Academies Press. doi: 10.17226/11985.
×
Page 148
Suggested Citation:"Appendix B Glossary and Acronyms." Institute of Medicine and National Research Council. 2007. Advancing Nuclear Medicine Through Innovation. Washington, DC: The National Academies Press. doi: 10.17226/11985.
×
Page 149
Suggested Citation:"Appendix B Glossary and Acronyms." Institute of Medicine and National Research Council. 2007. Advancing Nuclear Medicine Through Innovation. Washington, DC: The National Academies Press. doi: 10.17226/11985.
×
Page 150
Next: Appendix C Commercially Available Radiopharmaceuticals »
Advancing Nuclear Medicine Through Innovation Get This Book
×
Buy Paperback | $65.00 Buy Ebook | $54.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Nearly 20 million nuclear medicine procedures are carried out each year in the United States alone to diagnose and treat cancers, cardiovascular disease, and certain neurological disorders. Many of the advancements in nuclear medicine have been the result of research investments made during the past 50 years where these procedures are now a routine part of clinical care. Although nuclear medicine plays an important role in biomedical research and disease management, its promise is only beginning to be realized.

Advancing Nuclear Medicine Through Innovation highlights the exciting emerging opportunities in nuclear medicine, which include assessing the efficacy of new drugs in development, individualizing treatment to the patient, and understanding the biology of human diseases. Health care and pharmaceutical professionals will be most interested in this book's examination of the challenges the field faces and its recommendations for ways to reduce these impediments.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!